Key result
An atrial fibrillation polygenic risk score was associated with cardioembolic stroke, independent of clinical risk factors.
Why the study?
Does an atrial fibrillation polygenic risk score associate with cardioembolic stroke risk?
Case-Control (n=34,216)
Yes
Does an atrial fibrillation polygenic risk score associate with cardioembolic stroke risk?
Genetic risk for atrial fibrillation is associated with cardioembolic stroke independent of clinical risk factors, highlighting its potential as a biomarker for AF-related strokes.
Answers are grounded in this paper and cite their sources.
AF PRS may support cardioembolic stroke risk stratification; hypothesis-generating and requires prospective validation before clinical use.
Objective We sought to assess whether genetic risk factors for atrial fibrillation can explain cardioembolic stroke risk. Methods We evaluated genetic correlations between a prior genetic study of AF and AF in the presence of cardioembolic stroke using genome-wide genotypes from the Stroke Genetics Network (N = 3,190 AF cases, 3,000 cardioembolic stroke cases, and 28,026 referents). We tested whether a previously-validated AF polygenic risk score (PRS) associated with cardioembolic and other stroke subtypes after accounting for AF clinical risk factors. Results We observed strong correlation between previously reported genetic risk for AF, AF in the presence of stroke, and cardioembolic stroke (Pearson’s r=0.77 and 0.76, respectively, across SNPs with p < 4.4 × 10 −4 in the prior AF meta-analysis). An AF PRS, adjusted for clinical AF risk factors, was associated with cardioembolic stroke (odds ratio (OR) per standard deviation (sd) = 1.40, p = 1.45×10 −48 ), explaining ∼20% of the heritable component of cardioembolic stroke risk. The AF PRS was also associated with stroke of undetermined cause (OR per sd = 1.07, p = 0.004), but no other primary stroke subtypes (all p > 0.1). Conclusions Genetic risk for AF is associated with cardioembolic stroke, independent of clinical risk factors. Studies are warranted to determine whether AF genetic risk can serve as a biomarker for strokes caused by AF.
No takes yet. Share an insight, caveat, or question.
Pulit et al. (2017) conducted a case-control in Atrial fibrillation and cardioembolic stroke (n=34,216). Atrial fibrillation polygenic risk score (PRS) vs. Referents was evaluated on Association with cardioembolic stroke (OR 1.40, p=1.45×10^-48). An atrial fibrillation polygenic risk score was associated with cardioembolic stroke, independent of clinical risk factors.
Synapse has enriched 10 related papers. Consider them for comparative context: